SPECIFICITY AND SENSITIVITY OF IMMUNOCYTOCHEMISTRY FOR DETECTING P-GLYCOPROTEIN IN HEMATOLOGICAL MALIGNANCIES

被引:17
作者
GALA, JL
MCLACHLAN, JM
BELL, DR
MICHAUX, JL
MA, DDF
机构
[1] ROYAL N SHORE HOSP,DEPT HAEMATOL,SYDNEY,NSW,AUSTRALIA
[2] UNIV CATHOLIQUE LOUVAIN,HOP ST LUC,DEPT HAEMATOL,B-1200 BRUSSELS,BELGIUM
[3] ROYAL N SHORE HOSP,DEPT ONCOL,SYDNEY,NSW,AUSTRALIA
关键词
D O I
10.1136/jcp.47.7.619
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To determine the optimal working conditions of the alkaline phosphatase-antialkaline phosphatase (APAAP) method to establish a specific and sensitive assay for the detection of low numbers of MDR positive cells in patients with hematological malignancies. Methods-Three monoclonal antibodies (C-219, JSB-1, MRK-16) were used for the detection of P-glycoprotein (P-gp) in cell lines and in samples from 43 patients with haematological malignancies. The results of the APAAP method were compared with western blotting for specificity and sensitivity. Results-Excellent correlation was obtained between optimised APAAP and western blotting, except in the case of multiple myeloma. JSB-1 seemed to be the more useful monoclonal antibody for the APAAP which was more sensitive than western blotting in its ability to detect single P-gp positive cells. Conclusions-Methods for P-gp detection, as defined by multidrug resistant (MDR) cell lines, are not necessarily optimal and specific for clinical samples and may lead to higher false positive and negative results, according to the conditions and the monoclonal antibodies used.
引用
收藏
页码:619 / 624
页数:6
相关论文
共 39 条
[1]  
BALL E, 1990, BLOOD S1, V76
[2]   DETECTION OF P-GLYCOPROTEIN IN OVARIAN-CANCER - A MOLECULAR MARKER ASSOCIATED WITH MULTIDRUG RESISTANCE [J].
BELL, DR ;
GERLACH, JH ;
KARTNER, N ;
BUICK, RN ;
LING, V .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (03) :311-315
[3]   P-GLYCOPROTEIN EXPRESSION AS A PREDICTOR OF THE OUTCOME OF THERAPY FOR NEUROBLASTOMA [J].
CHAN, HSL ;
HADDAD, G ;
THORNER, PS ;
DEBOER, G ;
LIN, YP ;
ONDRUSEK, N ;
YEGER, H ;
LING, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1608-1614
[4]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[5]   EXPRESSION OF THE MULTIPLE-DRUG RESISTANCE GENE (MDR-1) AND EPITOPE MASKING IN CHRONIC LYMPHATIC-LEUKEMIA [J].
CUMBER, PM ;
JACOBS, A ;
HOY, T ;
FISHER, J ;
WHITTAKER, JA ;
TSURUO, T ;
PADUA, RA .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) :226-230
[6]  
DALTON WS, 1989, BLOOD, V73, P747
[7]   DRUG-RESISTANCE IN MULTIPLE-MYELOMA AND NON-HODGKINS LYMPHOMA - DETECTION OF P-GLYCOPROTEIN AND POTENTIAL CIRCUMVENTION BY ADDITION OF VERAPAMIL TO CHEMOTHERAPY [J].
DALTON, WS ;
GROGAN, TM ;
MELTZER, PS ;
SCHEPER, RJ ;
DURIE, BGM ;
TAYLOR, CW ;
MILLER, TP ;
SALMON, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :415-424
[8]  
DANKS MK, 1985, CANCER RES, V45, P3220
[9]  
EPSTEIN J, 1989, BLOOD, V74, P913
[10]  
ERBER WN, 1986, LANCET, V1, P761